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LETTER TO EDITORRegarding “Cost-effectiveness of different screening
strategies for abdominal aortic aneurysm”
We read with interest the article by Wanhainen et al (J Vasc
Surg 2005;41:741-51), and greatly appreciate the development of
a stimulation model to assess cost-effectiveness of different screen-
ing strategies for abdominal aortic aneurysm (AAA). Before cost-
effectiveness of the screening is discussed, however, it should be
confirmed whether AAA screening saves lives.
To evaluate whether AAA screening reduces all-cause mortal-
ity, we conducted ameta-analysis of currently available population-
based, randomized controlled trials. We searched MEDLINE and
identified four trials of AAA screening in men 64 years old. The
trials included 125,576 total participants randomly assigned to
patients invited to screening and uninvited controls (Table).
Across the trials, 63% to 80% of invited participants (weighted
mean, 74%) attended ultrasound scanning. An intention-to-screen
analysis by means of a random effect model (DerSimonian-Laird
method) indicated that an invitation to attend screening reduced
AAA-related mortality but did not reduce all-cause mortality.
All-cause mortality, however, was lower in attenders for screening
than in nonattenders and/or controls on the basis of a per-
protocol analysis.
An explanation could be that people who refuse screening are
older and would be expected to include a high proportion of those
unwell from other causes.1 On the other hand, potential benefits of
AAA screening may occur because of improved management of
cardiovascular risk factors in those invited to screening.2 Discus-
Characteristics of trials and meta-analyses of outcomes
Viborg Country
Trial*
Western Austr
Trial†
Age (y) 64-73 65-83
Total participants (No.) 12,639 38,704
Mean follow-up (y) 4.3 3.6¶
Attended screening (%) 77 63
Aneurysm-related
mortality (%)
Screening / control 0.142/0.428 0.093/0.12
Odds ratio (95%
confidence interval)
0.33 (0.16-0.70) 0.72 (0.39-1
All-cause mortality (%)
Screening (attenders/
non-attenders)
14.8 (12.4/22.8) 11.5 (8.8/16
Control (non-attenders
 control)
16.2 (17.4) 13.3 (14.1)
Odds ratio (95%
confidence interval)
Screening vs control 0.90 (0.82-0.99) 0.85 (0.80-0
Attenders vs non-
attenders
0.48 (0.41-0.55) 0.50 (0.45-0
Attenders vs control 0.73 (0.66-0.82) 0.63 (0.58-0
Attenders vs non-
attenders  control
0.67 (0.60-0.74) 0.59 (0.55-0
*BMJ 2005;330:750.
†BMJ 2004;329:1259.
‡Multicentre Aneurysm Screening Study; Lancet 2002;360:1531-9.
§Br J Surg 1995;82:1066-7.
¶Median.
Weighted mean excluding the Western Australia trial.
**Mean based on a random effect model (DerSimonian-Laird method).
1244sions about risk factors during screening may lead to some partic-
ipants changing their lifestyle.3 To improve cost-effectiveness of
AAA screening, we emphasized importance to get people invited
to the screening to attend it.
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MASS‡
Chichester Trial,
Men§ Total
65-74 65-80 64-83
67,800 6,433 125,576
4.1 2.5 4.0
80 73 74
0.192/0.333 0.312/0.527 0.163/0.290
0.58 (0.42-0.78) 0.59 (0.27-1.29) 0.57 (0.44-0.72)
11.1 (9.5/17.3) 16.6 (13.9/23.9) 11.9 (9.9/17.7)
11.4 (12.3) 15.7 (17.5) 12.7 (13.7)
0.97 (0.93-1.02) 1.07 (0.93-1.22) 0.94 (0.86-1.02)
0.50 (0.47-0.54) 0.52 (0.42-0.63) 0.50 (0.47-0.52)
0.82 (0.78-0.87) 0.87 (0.74-1.01) 0.75 (0.65-0.88)
0.75 (0.71-0.79) 0.76 (0.66-0.88) 0.69 (0.60-0.79)alia
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